Continued effort in research and development.

Aviva also has a rich pipeline of an additional 17,000 antibodies that are currently undergoing extensive western blot characterization and validation using a panel of 6 tissues and 6 cell lines. We anticipate releasing several thousand new antibody products in the year ahead as Aviva`s high throughput processing team characterizes these candidate new products.

Accommodating customer feedback.

Aviva welcomes customer input and encourages researchers to contact us with requests for specific antibodies to meet their research requirements at info@avivasysbio.com. If we have an antibody to meet your needs in our pipeline but not yet released, we will make a concerted effort to move your target forward in the queue and alert you to the availability of the new antibody once released.

Aviva Systems Biology Corporation Downloads

Aviva Systems Biology - Model MMP9 (OKEH00522) - ELISA Kit (Rat) - Brochure